/CSMYF
CSMYF Stock - COSMOS Pharmaceutical Corporation
Healthcare|Medical - PharmaceuticalsOTC
$48.27+0.00%
+$0.00 (+0.00%) • Jan 13
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.59
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $53.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CSMYF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$47.79 – $48.75
TARGET (TP)$55.51
STOP LOSS$44.41
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.28
52W High$61.39
52W Low$46.06
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.01T | $964.99B | $827.70B | $755.41B | $726.42B |
| Gross Profit | $213.28B | $188.31B | $168.72B | $151.45B | $145.11B |
| Gross Margin | 21.1% | 19.5% | 20.4% | 20.0% | 20.0% |
| Operating Income | $40.40B | $31.50B | $30.13B | $29.80B | $33.15B |
| Net Income | $30.98B | $24.45B | $23.80B | $23.16B | $27.16B |
| Net Margin | 3.1% | 2.5% | 2.9% | 3.1% | 3.7% |
| EPS | $390.86 | $308.61 | $600.95 | $584.74 | $685.77 |
Company Overview
COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. As of May 31, 2022, the company operated 1,244 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was incorporated in 1983 and is headquartered in Fukuoka, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CSMYFBeat Rate
53%
Last 19 quarters
Avg Surprise
+25.1%
EPS vs Estimate
Beats / Misses
10/9
Last 12 quarters
Latest EPS
$0.52
Q1 2026
EPS Surprise History
Q2 24
+114.1%
$0.97vs$0.45
Q3 24
-7.2%
$0.57vs$0.61
Q4 24
+15.8%
$0.70vs$0.61
Q1 25
+24.0%
$0.53vs$0.43
Q2 25
+30.6%
$0.66vs$0.51
Q3 25
-3.1%
$0.76vs$0.78
Q4 25
-99.4%
$0.00vs$0.76
Q1 26
-2.8%
$0.52vs$0.54
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 13, 2026 | — | — | — | — |
Q1 2026 | Jan 13, 2026 | $0.54 | $0.52 | -2.8% | ✗ MISS |
Q4 2025 | Oct 14, 2025 | $0.76 | $0.00 | -99.4% | ✗ MISS |
Q3 2025 | Jul 11, 2025 | $0.78 | $0.76 | -3.1% | ✗ MISS |
Q2 2025 | Apr 14, 2025 | $0.51 | $0.66 | +30.6% | ✓ BEAT |
Q1 2025 | Jan 10, 2025 | $0.43 | $0.53 | +24.0% | ✓ BEAT |
Q4 2024 | Oct 11, 2024 | $0.61 | $0.70 | +15.8% | ✓ BEAT |
Q3 2024 | Jul 12, 2024 | $0.61 | $0.57 | -7.2% | ✗ MISS |
Q2 2024 | Apr 12, 2024 | $0.45 | $0.97 | +114.1% | ✓ BEAT |
Q1 2024 | Jan 12, 2024 | $0.42 | $0.87 | +108.8% | ✓ BEAT |
Q3 2023 | Aug 31, 2023 | $0.57 | $1.13 | +97.6% | ✓ BEAT |
Q2 2023 | May 31, 2023 | $0.62 | $1.36 | +120.1% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $0.51 | $0.92 | +80.3% | ✓ BEAT |
Q1 2023 | Jan 13, 2023 | $132.11 | $121.67 | -7.9% | ✗ MISS |
Q4 2022 | Oct 11, 2022 | $155.96 | $163.67 | +4.9% | ✓ BEAT |
Q3 2022 | Jul 11, 2022 | $171.60 | $169.20 | -1.4% | ✗ MISS |
Q2 2022 | Apr 11, 2022 | $140.47 | $131.57 | -6.3% | ✗ MISS |
Q1 2022 | Jan 11, 2022 | $134.01 | $126.32 | -5.7% | ✗ MISS |
Q4 2021 | Oct 11, 2021 | $167.05 | $157.68 | -5.6% | ✗ MISS |
Q3 2021 | Jul 12, 2021 | $117.39 | $140.80 | +19.9% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about CSMYF
What is CSMYF's current stock price?
COSMOS Pharmaceutical Corporation (CSMYF) is currently trading at $48.27 per share. The stock has moved +0.00% today.
What is the analyst price target for CSMYF?
No analyst price targets are currently available for this stock.
What sector is COSMOS Pharmaceutical Corporation in?
COSMOS Pharmaceutical Corporation operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.
What is CSMYF's market cap?
COSMOS Pharmaceutical Corporation has a market capitalization of $3.83 billion, making it a mid-cap company.
Does CSMYF pay dividends?
No, COSMOS Pharmaceutical Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAKBLF
ALK-Abelló A/S
$36.10
Mkt Cap: $7.3B
CLCGY
Clicks Group Limited
$42.40
Mkt Cap: $5.0B
FLMNF
Fielmann AG
$60.22
Mkt Cap: $5.1B
FLMNY
Fielmann AG
$10.21
Mkt Cap: $4.3B
GEDSF
Gedeon Richter PLC
$24.85
Mkt Cap: $4.5B
GNGBF
Getinge AB (publ)
$24.48
Mkt Cap: $6.2B
LABFF
Laboratorios Farmaceuticos Rovi, S.A.
$90.61
Mkt Cap: $4.6B
RADLY
Raia Drogasil S.A.
$4.44
Mkt Cap: $7.5B
SDGCF
Sundrug Co.,Ltd.
$28.18
Mkt Cap: $3.3B
WLCGF
Welcia Holdings Co., Ltd.
$16.41
Mkt Cap: $3.4B
Explore stocks similar to CSMYF for comparison